Skin Cancer Prevention: Recent Evidence from Randomized Controlled Trials

Current Dermatology Reports

Volumn 1, Issue 3, 2012, Pages 123-130

  Green, Adèle C ^a,b,c   Harwood, Catherine A ^d   Lear, John ^b   Proby, Charlotte ^e   Sinnya, Sudipta ^f   Soyer, H Peter ^f  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

5 fluorouracil; 5 FU; Actinic keratosis; AK; Basal cell carcinoma; BCC; Clinical trials; Dermoscopy; Digital photography; Interventions; Outcome measures; Prevention; Randomized controlled trials; RCTs; SCC; Skin cancer; Squamous cell carcinoma; Sunscreen; Topical treatment

Indexed keywords

AFAMELANOTIDE; ANTIOXIDANT; BETA CAROTENE; CALCINEURIN INHIBITOR; DICLOFENAC; ETRETIN; FLUOROURACIL; IMIQUIMOD; LIPOSOME; OMEGA 3 FATTY ACID; PLACEBO; RAPAMYCIN; RETINOIC ACID; RETINOID; SUNSCREEN;

ACTINIC KERATOSIS; CRYOTHERAPY; DISEASE COURSE; EPILUMINESCENCE MICROSCOPY; ERYTHEMA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MELANOMA; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKIN BIOPSY; SKIN CANCER; SYSTEMATIC REVIEW (TOPIC); UNSPECIFIED SIDE EFFECT; XERODERMA PIGMENTOSUM;

EID: 84973540791     PISSN: None     EISSN: 21624933     Source Type: Journal    
DOI: 10.1007/s13671-012-0015-9     Document Type: Review

References (41)

1. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, Coldiron BM. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010; 146(3): 283-7.
2. Soyer HP, Rigel DS, Wurm EMT Dermatology. In: Bolognia JL, Jorizzo JL, Schaffer JV (editors) Vol 1. Actinic keratosis, basal cell carcinoma and squamous cell carcinoma. 3rd edn. Mosby/Elsevier, 2012.
3. AIHW. Cancer survival and prevalence in Australia: cancers diagnosed from 1982 to 2004. In. Canberra; 2008.
4. Jemal A, Saraiya M, Patel P, Cherala SS, Barnholtz-Sloan J, Kim J, et al. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol. 2011; 65(5): S17-S25. e13.
5. Housman TS, Feldman SR, Williford PM, Fleischer Jr AB, Goldman ND, Acostamadiedo JM, Chen GJ. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol. 2003; 48(3): 425-9.
6. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006; 184(1): 6-10.
7. Weinstock MA. The struggle for primary prevention of skin cancer. American Journal of Preventive Medicine. 2008; 34(2): 171-2.
8. •• Hirst NG, Gordon LG, Scuffham PA, Green AC. Lifetime cost-effectiveness of skin cancer prevention through promotion of daily sunscreen use. Value Health. 2012; 15(2): 261-8. This paper provides a newly published analysis of the cost-effectiveness of sunscreen application for skin cancer preventon based on RCT evidence.
9. • Neidecker MV, Davis-Ajami ML, Balkrishnan R, Feldman SR: Pharmacoeconomic considerations in treating actinic keratosis. Pharmacoeconomics 2009; 27(6): 451-64. This paper illustrates the economic importance of preventing rather than treating AKs.
10. Frost C, Williams G, Green A. High incidence and regression rates of solar keratoses in a Queensland Community. J Invest Dermatol. 2000; 115(2): 273-7.
11. Holmes C, Foley P, Freeman M, Chong AH. Solar keratosis: Epidemiology, pathogenesis, presentation and treatment. Australas J Dermatol. 2007; 48(2): 67-76.
12. El Ghissassi F, Baan R, et al. A review of human carcinogens--part D: radiation. Lancet Oncol. 2009; 10: 751-2.
13. • Lin JS, Eder M, Weinmann S: Behavioral counseling to prevent skin cancer: a systematic review for the U. S. Preventive Services Task Force. Annals of Internal Medicine. 2011; 154(3): 190-201. This systematic review of studies of behavioral counseling to prevent skin cancer complements the present review, which does not cover behavioral counseling RCTs, since none have skin cancer as primary endpoint.
14. Dobbinson SJ, White V, Wakefield MA, Jamsen KM, White V, Livingston PM, English DR, Simpson JA. Adolescents' use of purpose built shade in secondary schools: cluster randomised controlled trial. BMJ 2009; 338.
15. Hillhouse J, Turrisi R, Stapleton J, Robinson J. A randomized controlled trial of an appearance-focused intervention to prevent skin cancer. Cancer. 2008; 113(11): 3257-66.
16. Bath-Hextall F, Leonardi-Bee J, Somchand N, Webster A, Delitt J, Perkins W. Interventions for preventing non-melanoma skin cancers in high-risk groups. Cochrane Database of Systematic Reviews (Online) (4). 2007.
17. Yarosh D, Klein J, O'Connor A, Hawk J, Rafal E, Wolf P. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Lancet. 2001; 357(9260): 926-9.
18. Hadley G, Derry S, Moore RA. Imiquimod for actinic keratosis: systematic review and meta-analysis. J Invest Dermatol. 2006; 126(6): 1251-5.
19. Green A, Battistutta D, Hart V, Leslie D, Marks G, Williams G, Gaffney P, Parsons P, Hirst L, Frost C, et al. The Nambour skin cancer and actinic eye disease prevention trial: design and baseline characteristics of participants. Control Clin Trials. 1994; 15(6): 512-22.
20. Green A, Williams G, Nèale R, Hart V, Leslie D, Parsons P, Marks GC, Gaffney P, Battistutta D, Frost C, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet. 1999; 354(9180): 723-9.
21. van der Pols JC, Williams GM, Pandeya N, Logan V, Green AC. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiology Biomarkers & Prevention. 2006; 15(12): 2546-8.
22. Darlington S, Williams G, Neale R, Frost C, Green A. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol. 2003; 139(4): 451-5.
23. Pandeya N, Purdie DM, Green A, Williams G. Repeated occurrence of basal cell carcinoma of the skin and multifailure survival analysis: follow-up data from the nambour skin cancer prevention trial. Am J Epidemiol. 2005; 161(8): 748-54.
24. •• Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. Journal Clinical Oncology. 2011; 29(3): 257-63. This report is the first RCT evidence that sunscreen application can prevent melanoma.
25. •• Alberu J, Pascoe MD, Campistol JM, Schena FP, del Carmen Rial M, Polinsky M, et al. Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT Trial. Transplantation 2011; 92: 303-10. This report provides RCT evidence that sirolimus-based immunosuppression can prevent skin cancer in renal transplant recipients who are at high risk of skin cancer.
26. •• Weinstock MA, Bingham SF, DiGiovanna JJ, Rizzo AE, Marcolivio K, Hall R, Eilers D, Naylor M, Kirsner R, Kalivas J et al. Tretinoin and the prevention of keratinocyte carcinoma (basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial. J Invest Dermatol. 2012. This paper provides the results of a well-conducted trial of tretinoin use for skin cancer prevention.
27. • Askew DA, Mickan SM, Soyer HP, Wilkinson D. Effectiveness of 5-fluorouracil treatment for actinic keratosis - a systematic review of randomized controlled trials. International Journal Dermatology. 2009; 48(5): 453-63. This systematic review of 5-FU and AK treatment includes both small, short-term studies and large, longer term RCTs.
28. • Fayter D, Corbett M, Heirs M, Fox D, Eastwood A. A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin. 2010. Health technology assessment (Winchester, England) 14(37): 1-288. This quality systematic review of photodynamic therapy includes treatment of AKs.
29. ClinicalTrials. gov, US National Instit Health [cited 2012 April]; Available from: [www. clinicaltrials. gov].
30. Epstein E. Quantifying actinic keratosis: assessing the evidence. Am J Clin Dermatol. 2004; 5(3): 141-4.
31. Roewert-Huber J, Stockfleth E, Kerl H. Pathology and pathobiology of actinic (solar) keratosis - an update. Br J Dermatol. 2007; 157: 18-20.
32. Ramos-Ceballos FI, Ounpraseuth ST, Horn TD. Diagnostic concordance among dermatopathologists using a three-tiered keratinocytic intraepithelial neoplasia grading scheme. J Cutan Pathol. 2008; 35(4): 386-91.
33. Ko CJ. Actinic keratosis: facts and controversies. Clin Dermatol. 2010; 28(3): 249-53.
34. Quaedvlieg PJ, Tirsi E, et al. Actinic keratosis: how to differentiate the good from the bad ones? Eur J Dermatol. 2006; 16: 335-9.
35. Criscione VD WM, et al. Actinic keratoses: natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer 2009; 115: 2523-30.
36. •• Heal CF, Weedon D, Raasch BA, Hill BT, Buettner PG: Agreement between histological diagnosis of skin lesions by histopathologists and a dermato-histopathologist. International Journal of Dermatology 2009; 48(12): 1366-9. This paper, which discusses many of the difficult issues relating to AK assessment, is important for its discussion of histopathological as well as clinical aspects.
37. Euvrard S, Boissonnat P, Roussoulières A, Kanitakis J, Decullier E, Claudy A, Sebbag L. Effect of everolimus on skin cancers in calcineurin inhihitor-treated heart transplant recipients. Transpl Int. 2010; 23(8): 855-7.
38. Weinstock MA, Bingham SF, Cole GW, et al. Reliability of counting actinic keratoses before and after brief consensus discussion: the VA topical tretinoin chemoprevention (VATTC) trial. Arch Dermatol. 2001; 137: 1055-8.
39. Wurm E. SH: Scanning for melanoma. Australian Prescriber. 2010; 33: 150-5.
40. Akay BN, Kocyigit P, Heper AO, Erdem C. Dermatoscopy of flat pigmented facial lesions: diagnostic challenge between pigmented actinic keratosis and lentigo maligna. Br J Dermatol. 2010; 163(6): 1212-7.
41. Zalaudek I, Whiteman D, Rosendahl C, Menzies SW, Green AC, Hersey P, Argenziano G. Update on melanoma and non-melanoma skin cancer. Expert Rev Anticancer Ther. 2011; 11(12): 1829-32.